CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 129 filers reported holding CHEMOCENTRYX INC in Q4 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,966,000 | +155.2% | 115,482 | +22.4% | 0.00% | +200.0% |
| Q2 2022 | $2,338,000 | -44.5% | 94,337 | -43.9% | 0.00% | 0.0% |
| Q1 2022 | $4,216,000 | +918.4% | 168,170 | +1378.2% | 0.00% | – |
| Q4 2021 | $414,000 | -77.8% | 11,377 | -89.6% | 0.00% | -100.0% |
| Q3 2021 | $1,869,000 | +644.6% | 109,274 | +483.4% | 0.00% | – |
| Q2 2021 | $251,000 | -91.7% | 18,730 | -68.3% | 0.00% | -100.0% |
| Q1 2021 | $3,028,000 | -62.5% | 59,098 | -54.7% | 0.00% | -66.7% |
| Q4 2020 | $8,082,000 | +24390.9% | 130,528 | +21764.0% | 0.00% | – |
| Q3 2020 | $33,000 | -99.6% | 597 | -99.6% | 0.00% | -100.0% |
| Q2 2020 | $8,234,000 | -77.2% | 143,105 | -84.1% | 0.00% | -82.4% |
| Q1 2020 | $36,191,000 | +10.8% | 900,727 | +9.1% | 0.02% | +54.5% |
| Q4 2019 | $32,652,000 | +377.5% | 825,592 | -18.1% | 0.01% | +266.7% |
| Q3 2019 | $6,838,000 | +85.4% | 1,008,616 | +154.3% | 0.00% | +200.0% |
| Q2 2019 | $3,689,000 | +4629.5% | 396,612 | +6937.1% | 0.00% | – |
| Q1 2019 | $78,000 | -55.2% | 5,636 | -64.6% | 0.00% | – |
| Q4 2018 | $174,000 | +126.0% | 15,934 | +161.6% | 0.00% | – |
| Q3 2018 | $77,000 | +185.2% | 6,090 | +195.9% | 0.00% | – |
| Q2 2018 | $27,000 | +58.8% | 2,058 | +64.6% | 0.00% | – |
| Q1 2018 | $17,000 | +30.8% | 1,250 | -44.8% | 0.00% | – |
| Q4 2017 | $13,000 | +160.0% | 2,265 | +265.9% | 0.00% | – |
| Q3 2017 | $5,000 | -95.9% | 619 | -96.3% | 0.00% | – |
| Q4 2016 | $123,000 | – | 16,561 | +75177.3% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 22 | -98.1% | 0.00% | – |
| Q2 2016 | $5,000 | -70.6% | 1,136 | -46.4% | 0.00% | – |
| Q4 2015 | $17,000 | 0.0% | 2,118 | -23.1% | 0.00% | – |
| Q3 2015 | $17,000 | +750.0% | 2,754 | +1097.4% | 0.00% | – |
| Q2 2015 | $2,000 | -81.8% | 230 | -84.7% | 0.00% | – |
| Q1 2015 | $11,000 | -31.2% | 1,501 | -34.1% | 0.00% | – |
| Q4 2014 | $16,000 | – | 2,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |